ICU: Clinical Trials

3 trials for ICU, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow ICU: new trials by email Literature Review of ICU trials Research Report on ICU

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Randomized Controlled Pilot Study
Cardiopeptidin, 50 ml of normal saline intravenous infusion - Myocardial Injury, ICU
Phase 4CompletedNanfang Hospital, Southern Medical University2342024-03-012026-10-01
Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients
N acetyl cysteine, Placebo - Linezolid, Antioxidant
Phase 4CompletedHelwan University2502023-08-012025-07-14
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
Hydromorphone, Fentanyl, Butorphanol - Hydromorphone, Analgesia
Phase 4CompletedNanfang Hospital, Southern Medical University5302020-09-042026-09-02

Narrower conditions

Agnosia (1)  ·  Critical Illness (1)  ·  Thrombocytopenia (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Blood Platelet Disorders (1)  ·  Cytopenia (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Perceptual Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Acetylcysteine (1)  ·  Butorphanol (1)  ·  Fentanyl (1)  ·  Hydromorphone (1)

Sponsors

Nanfang Hospital, Southern Medical University (2)  ·  Helwan University (1)

Countries

China (2)  ·  Egypt (1)

Top investigators

Mohamed Abdeltawab, Pharm D (1)

Results publications

PMID 41577060